We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Biomarkers from Discovery to Clinical Diagnostics Applications of Single-Molecule Array (Simoa) Technology

Video   Mar 17, 2015

 


About the Speaker
Andreas Jeromin, PhD, has established research programs in translational neuroscience in both industry and biotech for the last 15 years and co-authored more than 100 publications. He has also been elected a member of the Dana Alliance for Brain Initiatives. Andreas Jeromin has led biomarker qualification programs in diagnostics and therapeutics in acute neurological injury and neurodegeneration in roles with increased responsibilities. This included several drug development program from POC to a NINDS-supported phase III trial (Protect III). He also supports as member of the SABs or steering committee, several biomarker qualification efforts such as ADNI, the Coalition against Major Diseases (CAMD) directed by the Critical Path Institute (C-PATH), the Alzheimer's Association CSF QC and biomarker assay standardization initiatives in other CNS disorders, including MS (Accelerated Cure), ALS and PD. He is the founder and CSO of Atlantic Biomarkers, LLC, and joined Quanterix, Inc. as scientific and medical advisor in 2014.

 
 
 
Advertisement
 

Recommended Videos

Teach Me in 10 – Not All Plants Want To Be Eaten With Dr Steven Gundry

Video

In this installment of Teach Me in 10 we're joined by the New York Times best-selling author of "The Plant Paradox" and former cardiac surgeon Dr Steven Gundry, who discusses why "not all plants want to be eaten".

WATCH NOW

Teach Me in 10 – Understanding COVID-19 Through "Omics" With Dr Clare Paterson

Video

In a COVID-19 special of Teach Me in 10, we're joined by Dr Clare Paterson, senior clinical R&D scientist at SomaLogic, who is currently working on using "omics" approaches to understand the biology of SARS-CoV-2.

WATCH NOW

COVID-19 - The Big Questions 6 Months On

Video

The global scientific machine has jumped into action to combat the coronavirus, but there are still many unanswered questions surrounding the nature of immunity, whether the virus is mutating and how effective a vaccine may be.

WATCH NOW

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE